Ask Us
Register
Monitoring Medicines for over 2,573,000 Members
Australia
Brasil
Deutschland
España
France
United Kingdom
United States
English
Español
What is MediGuard?
Drugs A to Z
Conditions
Research
About Us
Recent Pages:
Detrol satisfaction and usage data | Monitoring more than 10,000 patients | Drug safety information
/
Camila satisfaction and usage data | Monitoring more than 1,300 patients | Drug safety information
/
Celexa satisfaction and usage data | Monitoring more than 30,000 patients | Drug safety information
Please correct the highlighted fields below.
Alerts for
Pioglitazone
Title
Date Published
Source
Neue Anwendungsbeschränkungen und Vorsichtsmaßnahmen für Medikamente mit dem Wirkstoff Pioglitazon
2011-08-01
La AEMPS Alerta De Un Pequeño Riesgo De Cáncer De Vejiga Con Pioglitazona
2011-07-26
TGA Warns of Risk of Bladder Cancer with Pioglitazone
2011-07-25
MHRA Warns Healthcare Professionals about Increased Risk Of Bladder Cancer With Pioglitazone
2011-07-25
La Agencia Española De Medicamentos Y Productos Sanitarios (AEMPS) Anuncia Una Revisión De La Seguridad De La Pioglitazona
2011-07-11
L’AFSSAPS demande la suspension de l’utilisation des médicaments contenant de la pioglitazone (Actos et Competact) en raison d’une faible augmentation du risque de cancer de la vessie
2011-06-18
FDA Issues Safety Update for Ongoing Safety Review of Actos (Pioglitazone) and Increased Risk of Bladder Cancer
2011-06-15
Behörde empfiehlt, Pioglitazon wegen erhöhtem Risiko für Blasenkrebs nicht mehr anzuwenden
2011-06-13
Riesgo De Insuficiencia Cardiaca Con El Uso de Insulina Y Pioglitazona
2011-03-16
Pioglitazone (Actos, Competact) Combined With Insulin Linked To Increased Risk of Heart Failure
2011-03-11
FDA Announces Safety Review of Actos (Pioglitazone) for Cancer Risk
2010-09-17
Thiazolidinediones Associated with Increased Risk of Fractures
2009-06-08
Some Diabetes Drugs to Strengthen Warning on Heart Failure Risk
2007-08-14
See alerts for all drugs